iCoreConnect Inc. (NASDAQ:ICCT) Short Interest Update

iCoreConnect Inc. (NASDAQ:ICCT) was the target of a significant decline in short interest in July. As of July 31st, there was short interest totaling 41,300 shares, adeclineof50.2% from the July 15th total of 82,900 shares. Currently,4.9% of the shares of the stock are short sold. Based on an average daily volume of 61,500 shares, the short-interest ratio is currently 0.7 days. Based on an average daily volume of 61,500 shares, the short-interest ratio is currently 0.7 days. Currently,4.9% of the shares of the stock are short sold.

iCoreConnect Stock Down 68.6%

ICCT stock opened at $0.01 on Tuesday. iCoreConnect has a 52 week low of $0.01 and a 52 week high of $14.37. The stock has a market capitalization of $53,647.00, a P/E ratio of 0.00 and a beta of -1.46. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 7.93. The firm has a 50-day simple moving average of $0.13 and a 200-day simple moving average of $1.24.

Hedge Funds Weigh In On iCoreConnect

An institutional investor recently bought a new position in iCoreConnect stock. Sassicaia Capital Advisers LLC bought a new position in shares of iCoreConnect Inc. (NASDAQ:ICCT) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 14,000 shares of the company’s stock, valued at approximately $31,000. iCoreConnect makes up 0.1% of Sassicaia Capital Advisers LLC’s holdings, making the stock its 26th biggest position. Sassicaia Capital Advisers LLC owned 0.68% of iCoreConnect as of its most recent SEC filing. Institutional investors and hedge funds own 13.42% of the company’s stock.

About iCoreConnect

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.